TrialBMC medicine2015

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over.

Jane Warwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.